KALA BIO Announces Reverse Stock Split
Arlington, Massachusetts--(Newsfile Corp. - November 12, 2026) - KALA BIO, Inc. (NASDAQ: KALA) ("KALA BIO" or the "Company"), today announced that it intends to effect a reverse stock split of its common stock, par value $0.001 per share (the "common stock"), at a ratio of 1 post-split share for every 30 pre-split shares. The reverse stock split will become effective at 4:05 p.m. on Friday, November 13, 2026. The Company's common stock will continue to be traded on the Nasdaq Capital Market...
2026-11-12 8:00 AM EST
KALA BIO Provides CEO Update and Preliminary Third Quarter 2026 Financial Results
New York, New York--(Newsfile Corp. - November 9, 2026) - KALA BIO, Inc. (NASDAQ: KALA) today announced preliminary unaudited financial results for the quarter ended September 30, 2026. Preliminary Third Quarter 2026 Results Net loss of approximately $0.8 million for the third quarter of 2026, compared to $7.6 million for the third quarter of 2025. Net loss of approximately $4.0 million for the nine months ended September 30, 2026, compared to $27.7 million for the same period in 2025. Cash,...
2026-11-09 8:00 AM EST
KALA Bio Signs Non-Binding LOI to Acquire Nationwide Telehealth Platform with Approximately $48 Million in Sales Since Inception
New York, New York--(Newsfile Corp. - September 29, 2026) - KALA Bio, In
2026-09-29 7:30 AM EDT